In a scientific first, researchers from Vanderbilt University and the University of California, San Diego, have generated a ...

Bristol Myers (BMY) receives FDA approval for label updates for Breyanzi and Abecma, that can ease access to the cancer cell therapies. Read more here.

Cancer is when abnormal cells divide in an uncontrolled way. Some cancers may eventually spread into other tissues. There are more than 200 different types of cancer. 1 in 2 people in the UK will get ...

BASKING RIDGE, N.J.-- (BUSINESS WIRE)--Jul 9, 2025--TURALIO® Final Long-Term Data Showed Sustained Clinical Benefit in Patients with Tenosynovial Giant Cell Tumor from Open-Label Extension of ...

Final long-term efficacy and safety results from the open-label extension of the ENLIVEN phase 3 trial showed a sustained clinical benefit from long-term treatment with TURALIO ® (pexidartinib ...